The Research Center of Leukemia and Childhood Malignancies

Cancer is the leading cause of death from disease in children. Leukemias and hematopoietic malignancies are the most common types of cancer in children.

Although mortality rates for these malignancies have declined significantly, the cure involves intensive and toxic chemotherapy.

Our ultimate goal is to cure all children with leukemia and cancer with personalized adjustment of therapy to the severity of the disease and to the molecular genetic abnormalities in the cancer cells.

A prerequisite for the achievement of this goal is better understanding of how children get leukemia and what are the differences between normal and cancer cells.

This can be realistically achieved by translational research utilizing modern sophisticated genetic and biochemical tools.

Head: Prof. Shai Izraeli

Lab Team: Yehudit Birger PhD - senior scientist, lab manager, Inna Muler - Technician, Liat Goldberg PhD - Postdoctoral fellow

PhD Students: Asher Castiel, Ahuvit David, Ithamar Ganmore, Nir Gefen, Liron Frishman-Levi, Libi Hertzberg, Gil Smooha